A detailed history of Van Eck Associates Corp transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 58,472 shares of LNTH stock, worth $5.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
58,472
Previous 36,868 58.6%
Holding current value
$5.05 Million
Previous $2.96 Million 118.55%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$77.7 - $123.62 $1.68 Million - $2.67 Million
21,604 Added 58.6%
58,472 $6.47 Million
Q2 2024

Jul 31, 2024

BUY
$58.87 - $83.05 $2.17 Million - $3.06 Million
36,868 New
36,868 $2.96 Million
Q4 2022

Feb 08, 2023

SELL
$48.76 - $77.67 $15,798 - $25,165
-324 Reduced 2.78%
11,348 $578,000
Q3 2022

Oct 27, 2022

BUY
$61.42 - $86.29 $716,894 - $1.01 Million
11,672 New
11,672 $821,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.94B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.